25C-NBOH: Difference between revisions
>Tracer m Fixed experience link |
>LockPicker m NBOH-2CC to NBOH-2C-C |
||
Line 4: | Line 4: | ||
{{SubstanceBox/25C-NBOH}} | {{SubstanceBox/25C-NBOH}} | ||
'''25C-NBOH''' (also known as '''2C-C-NBOH''' and '''NBOH- | '''25C-NBOH''' (also known as '''2C-C-NBOH''' and '''NBOH-2C-C''') is novel synthetic [[Psychoactive class::psychedelic]] substance of the [[chemical class::phenethylamine]] chemical class that produces an array of visually-dominant and [[stimulating]] [[psychedelic]] effects when [[Routes of administration|administered]]. It is a closely related analog of [[25B-NBOMe]] and is reported to share most of its properties with the exception of a moderately reduced potency and a shorter duration. | ||
The name 25C-NBOH, which is short-hand for 2C-C-NBOH, is a derivative of the phenethylamine psychedelic [[2C-C]]. It was first synthesized and documented in 2011 by Martin Hansen at the University of Copenhagen.<ref>Martin Hansen (2011). "Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain." University of Copenhagen. Retrieved 27 June 2015.</ref> | The name 25C-NBOH, which is short-hand for 2C-C-NBOH, is a derivative of the phenethylamine psychedelic [[2C-C]]. It was first synthesized and documented in 2011 by Martin Hansen at the University of Copenhagen.<ref>Martin Hansen (2011). "Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain." University of Copenhagen. Retrieved 27 June 2015.</ref> | ||
Line 151: | Line 151: | ||
{{#ask: [[Category:25C-NBOH]][[Category:Experience]]|format=ul|Columns=1}} | {{#ask: [[Category:25C-NBOH]][[Category:Experience]]|format=ul|Columns=1}} | ||
Additional experience reports can be found here: | Additional experience reports can be found here: | ||
* [https://www.erowid.org/experiences/subs/exp_25CNBOH.shtml Erowid Experience Vaults: 25C-NBOH] | |||
*[https://www.erowid.org/experiences/subs/exp_25CNBOH.shtml Erowid Experience Vaults: 25C-NBOH] | |||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
Line 171: | Line 172: | ||
==Legality== | ==Legality== | ||
{{legalStub}} | {{legalStub}} | ||
*'''Brazil''' - As of December 10, 2018, 25C-NBOH has been added to Portaria SVS/MS nº 344. Possession, distribution and use of this substance is now considered illegal.<ref>List of controlled substances: Portaria SVS/MS nº 344 (Portuguese) | http://portal.anvisa.gov.br/lista-de-substancias-sujeitas-a-controle-especial</ref> | *'''Brazil''' - As of December 10, 2018, 25C-NBOH has been added to Portaria SVS/MS nº 344. Possession, distribution and use of this substance is now considered illegal.<ref>List of controlled substances: Portaria SVS/MS nº 344 (Portuguese) | http://portal.anvisa.gov.br/lista-de-substancias-sujeitas-a-controle-especial</ref> | ||
*'''United Kingdom''' - 25C-NBOH is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause.<ref>United Kingdom. (2014). Misuse of Drugs Act 1971 (S.I. 2014/1106). London: The Stationery Office Limited. Retrieved July 5, 2017, from http://www.legislation.gov.uk/uksi/2014/1106/made</ref> | *'''United Kingdom''' - 25C-NBOH is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause.<ref>United Kingdom. (2014). Misuse of Drugs Act 1971 (S.I. 2014/1106). London: The Stationery Office Limited. Retrieved July 5, 2017, from http://www.legislation.gov.uk/uksi/2014/1106/made</ref> | ||
Line 177: | Line 179: | ||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Research chemical]] | *[[Research chemical]] | ||
Line 185: | Line 188: | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/25C-NBOH 25C-NBOH (Wikipedia)] | *[https://en.wikipedia.org/wiki/25C-NBOH 25C-NBOH (Wikipedia)] | ||
*[https://isomerdesign.com/PiHKAL/explore.php?id=1252 25C-NBOH (Isomer Design)] | *[https://isomerdesign.com/PiHKAL/explore.php?id=1252 25C-NBOH (Isomer Design)] |